FBInvestor
Stocks / Fate Therapeutics Inc
Institutional Ownership

Fate Therapeutics Inc

CUSIP 31189P102COMFATEQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon